NIH-funded research Fellowship grant

Identifying genes that cause allergic airway inflammation using special mice

Official title: QTL mapping with Collaborative Cross mice defines genes that promote allergic airway inflammation

Funded at Vanderbilt University · NIH-11003280 · Data updated 2026-11-12

This study is looking at how certain genes affect asthma caused by allergens like mold, using a special group of mice to see how specific immune cells react to these allergens, which could help us find new ways to treat asthma.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startJanuary 1, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$34,164
NIH project number5F30AI176712-02
Project IDNIH-11003280 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from allergic asthma or related allergic conditions.

Less likely to help

Patients with non-allergic asthma or those whose asthma is not influenced by genetic factors may not benefit from this research.

What this research studies

This research investigates how certain genes influence allergic airway inflammation, particularly in asthma triggered by allergens like mold. By using a unique group of genetically diverse mice, the study aims to understand how specific immune cells, known as ILC2, respond to allergens and contribute to inflammation in the lungs. The researchers will map genetic traits associated with the activation and proliferation of these immune cells when exposed to common environmental allergens. This approach could lead to new insights into the mechanisms of asthma and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for asthma and allergic diseases by targeting the underlying genetic factors that drive inflammation.

How similar studies have gone: Previous research has shown success in using genetic mapping approaches to identify factors involved in asthma and allergic responses, indicating that this methodology is promising.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Rusznak, Mark — Vanderbilt University
  • Study coordinator: Rusznak, Mark

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.